EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

A scoping review of the measurement and analysis of frailty in randomised controlled trials

Scoping Review zur Messung und Analyse von Frailty in randomisierten kontrollierten Studien

Yanhe Sun, Miles D Witham, Andy Clegg, Rod S Taylor, Grace Dibben, David McAllister, Peter Hanlon iD

Age and Ageing · 01.11.2024 · 53 (11)

DOI: 10.1093/ageing/afae258 ↗

Auf einen Blick

Die Übersicht zeigt eine hohe Variabilität der Frailty-Messung in 415 RCTs. Am häufigsten wurden das Frailty-Phänotyp-Modell und der Frailty-Index verwendet.

Fragestellung

Wie wird Frailty in randomisierten kontrollierten Studien quantifiziert, in welchem Kontext und zu welchem Zweck wird sie erfasst?

Methode

Scoping Review von RCTs; Suche in fünf elektronischen Datenbanken; Extraktion von Interventionstyp, Frailty-Messung und Zweck der Frailty-Erfassung.

Ergebnisse

415 RCTs. Frailty diente zur Definition der Zielpopulation (166), als Outcome (156), als Effektmodifikator (61), als rein deskriptive Variable (42) oder als prognostischer Marker (78). Es wurden 28 Frailty-Messungen plus 29 studienspezifische Messungen genutzt.

Schlussfolgerung der Autor:innen

Die Frailty-Messung in RCTs ist stark variabel. Die Autor:innen betonen, dass das Verständnis der Eigenschaften der verwendeten Frailty-Messungen Priorität hat, damit Studienergebnisse die Versorgung von Menschen mit Frailty informieren können.

Kernaussagen

  • 415 RCTs untersuchten Frailty in verschiedenen Interventionskontexten
  • 28 Frailty-Messungen plus 29 studienspezifische Messungen wurden genutzt
  • Frailty-Phänotyp-Modell und Frailty-Index waren am häufigsten

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Scoping Review in der Zeitschrift Age and Ageing, online erschienen am 21.11.2024. Verfasst von Yanhe Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Health and Wellbeing, University of Glasgow, Glasgow, UK. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Frailty, Geriatric Assessment, Frail Elderly. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Frailty is of increasing interest in trials, either as a target of intervention, as an outcome or as a potential treatment modifier. However, frailty measurement is often highly variable. This scoping review assessed how frailty is quantified in randomised controlled trials (RCTs), in what context and for what purposes.

Methods

We searched five electronic databases for RCTs in which frailty was measured among trial participants. We extracted data on intervention type, the frailty measure used and the purpose for which frailty was assessed. We then compared these data according to reasons for frailty assessment.

Results

We identified 415 RCTs assessing frailty across a range of interventions. Frailty was used to define the target population (166 trials), as an outcome (156 trials), as an effect modifier examining interaction of frailty on treatment effect (61 trials), as a purely descriptive characteristic (42 trials) or as a prognostic marker examining the impact of frailty on future health outcome (78 trials). The trials used 28 different measures of frailty (plus 29 additional trial-specific measures). The frailty phenotype model was the most common overall (164 trials), for defining the target population (90/166 trials) and as an outcome (81/156 trials). The cumulative deficit model frailty index was also frequently used (102 trials) and was most common among trials assessing treatment effect modification (21/61 trials).

Conclusion

Frailty measurement in RCTs is highly variable. Understanding the properties of respective frailty measures and how these relate to frailty as encountered in clinical practice is a priority to ensure that trial findings can inform healthcare delivery for people living with frailty.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicFrailtyGeriatric AssessmentFrail ElderlyHumansAgedAged, 80 and over

Stichwörter der Autor:innen

frailtyinterventionsolder peopleoutcomesrandomised controlled trialssystematic reviewtrials

Autor:innen und Institutionen

  • School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • AGE Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne NHS Foundation Trust, Cumbria Northumberland Tyne and Wear NHS Foundation Trust and Newcastle University, Newcastle upon Tyne, UK.
  • Academic Unit for Ageing & Stroke Research, University of Leeds, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
  • MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK.
  • Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.

ORCID-Profile: Peter Hanlon

Zitieren

APA

Sun, Y., Witham, M. D., Clegg, A., Taylor, R. S., Dibben, G., McAllister, D., & Hanlon, P. (2024). A scoping review of the measurement and analysis of frailty in randomised controlled trials. Age and Ageing, 53(11). https://doi.org/10.1093/ageing/afae258

Vancouver

Sun Y, Witham MD, Clegg A, Taylor RS, Dibben G, McAllister D, et al. A scoping review of the measurement and analysis of frailty in randomised controlled trials. Age and Ageing. 2024;53(11). doi:10.1093/ageing/afae258

BibTeX
@article{Sun2024,
  author = {Sun, Yanhe and Witham, Miles D and Clegg, Andy and Taylor, Rod S and Dibben, Grace and McAllister, David and Hanlon, Peter},
  title = {A scoping review of the measurement and analysis of frailty in randomised controlled trials},
  journal = {Age and Ageing},
  year = {2024},
  volume = {53},
  number = {11},
  doi = {10.1093/ageing/afae258}
}
Kostenlos starten →